SYMQY (SymBio Pharmaceuticals) Net Interest Margin (Bank Only) %


SYMQY SymBio Pharmaceuticals Ltd SYMQY
34 GF Score
Price $0.56
GF Value $0.44
! 6 Warning Signs
View Full Analysis

What is SymBio Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

SYMQY
34GF Score
SymBio Pharmaceuticals Ltd SYMQY
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SymBio Pharmaceuticals (SYMQY) Overvalued in 2026?

Based on GuruFocus' analysis, SymBio Pharmaceuticals stock appears to be overvalued. The current stock price of $0.56 is trading 26.8% above its estimated GF Value™ of $0.44.

Key valuation signals for SYMQY:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $0.44 vs. price of $0.56 (26.8% above fair value)
  • GF Score™: 34/100 with 6 warning signs

No single metric tells the full story. See the SYMQY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SymBio Pharmaceuticals Business Description

Other Exchanges 4582:Japan
Address 1-28 Toranomon 4-chome, 7th Floor, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in development of new drugs with a primary focus on the treatment of rare diseases, mainly in the areas of oncology, hematology and multiple viral infections, and conduct integrated business activities that encompass search for new drug candidates, development, manufacturing, and sales.
34GF Score

Get the complete analysis for SYMQY

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$0.44
GF Value